Terms: = Liver cancer AND FUS, P35637, 2521, ENSG00000089280, TLS/CHOP, FUS-CHOP, CHOP, FUS1, TLS AND Prognosis
52 results:
1. Discovery of an independent poor-prognosis subtype associated with tertiary lymphoid structures in breast cancer.
Liu R; Huang X; Yang S; Du W; Chen X; Li H
Front Immunol; 2024; 15():1364506. PubMed ID: 38571938
[TBL] [Abstract] [Full Text] [Related]
2. Characterization of lymphocyte-rich hepatocellular carcinoma and the prognostic role of tertiary lymphoid structures.
Ahn B; Ahn HS; Shin J; Jun E; Koh EY; Ryu YM; Kim SY; Sung CO; Shim JH; Hong J; Kim K; Kang HJ
Liver Int; 2024 May; 44(5):1202-1218. PubMed ID: 38363048
[TBL] [Abstract] [Full Text] [Related]
3. Hepatitis B surface antigen positivity is associated with poor short- and long-term outcomes in patients with diffuse large B-cell lymphoma who received chop or R-chop.
Zhan Z; Guo W; Wan X; Wang B; Li J; Wang H; Li Z; Huang Y; Young KH; Bai O
Front Immunol; 2024; 15():1324113. PubMed ID: 38318173
[TBL] [Abstract] [Full Text] [Related]
4. The prognostic value of the tertiary lymphoid structure in gastrointestinal cancers.
Yu A; Cao M; Zhang K; Yang Y; Ma L; Zhang X; Zhao Y; Ma X; Fan Z; Han Z; Wang H
Front Immunol; 2023; 14():1256355. PubMed ID: 37868990
[TBL] [Abstract] [Full Text] [Related]
5. Furanocoumarin Notopterol: Inhibition of Hepatocellular Carcinogenesis through Suppression of cancer Stemness Signaling and Induction of Oxidative Stress-Associated Cell Death.
Huang TY; Yang CK; Chen MY; Yadav VK; Fong IH; Yeh CT; Cherng YG
Nutrients; 2023 May; 15(11):. PubMed ID: 37299411
[TBL] [Abstract] [Full Text] [Related]
6. Tertiary lymphoid structures predict the prognosis and immunotherapy response of cholangiocarcinoma.
Shang T; Jiang T; Lu T; Wang H; Cui X; Pan Y; Xu M; Pei M; Ding Z; Feng X; Lin Y; Li X; Tan Y; Feng F; Dong H; Wang H; Dong L
Front Immunol; 2023; 14():1166497. PubMed ID: 37234171
[TBL] [Abstract] [Full Text] [Related]
7. Primary breast B-cell non-Hodgkin’s lymphoma of the breast. Case Report and review of the literature.
Santiago-Sanabria L; Garza-Arrieta J; Porras-Ibarra GD; Malfavón-Farias M
Rev Colomb Obstet Ginecol; 2023 Mar; 74(1):53-67. PubMed ID: 37093942
[TBL] [Abstract] [Full Text] [Related]
8. Localization and density of tertiary lymphoid structures associate with molecular subtype and clinical outcome in colorectal cancer liver metastases.
Zhang C; Wang XY; Zuo JL; Wang XF; Feng XW; Zhang B; Li YT; Yi CH; Zhang P; Ma XC; Chen ZM; Ma Y; Han JH; Tao BR; Zhang R; Wang TQ; Tong L; Gu W; Wang SY; Zheng XF; Yuan WK; Kan ZJ; Fan J; Hu XY; Li J; Zhang C; Chen JH
J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36759015
[TBL] [Abstract] [Full Text] [Related]
9. Protective effect of tertiary lymphoid structures against hepatocellular carcinoma: New findings from a genetic perspective.
Jia W; Yao Q; Wang Y; Mao Z; Zhang T; Li J; Nie Y; Lei X; Shi W; Song W
Front Immunol; 2022; 13():1007426. PubMed ID: 36189217
[TBL] [Abstract] [Full Text] [Related]
10. Case report: Primary hepatocellular carcinoma with portal vein tumor thrombus characterized by active tumor immune microenvironment achieving a complete response following treatment of combined immunotherapy.
Zhong K; Xu Y; Cheng Y; Wen Y; Cai L; He G; Huang H; Fu S; Zhong X; Zheng Y; Chen T; Huang M; Pan M
Front Immunol; 2022; 13():999763. PubMed ID: 36119069
[TBL] [Abstract] [Full Text] [Related]
11. Peritumor tertiary lymphoid structures are associated with infiltrating neutrophils and inferior prognosis in hepatocellular carcinoma.
Zhang T; Lei X; Jia W; Li J; Nie Y; Mao Z; Wang Y; Tao K; Song W
Cancer Med; 2023 Feb; 12(3):3068-3078. PubMed ID: 36082777
[TBL] [Abstract] [Full Text] [Related]
12. Preoperative prediction of intra-tumoral tertiary lymphoid structures based on CT in hepatocellular cancer.
Li P; Liang Y; Zeng B; Yang G; Zhu C; Zhao K; Xu Z; Wang G; Han C; Ye H; Liu Z; Zhu Y; Liang C
Eur J Radiol; 2022 Jun; 151():110309. PubMed ID: 35468444
[TBL] [Abstract] [Full Text] [Related]
13. Downregulation of Low-density lipoprotein receptor-related protein 1B (LRP1B) inhibits the progression of hepatocellular carcinoma cells by activating the endoplasmic reticulum stress signaling pathway.
Zhen Z; Shen Z; Sun P
Bioengineered; 2022 Apr; 13(4):9467-9481. PubMed ID: 35389768
[TBL] [Abstract] [Full Text] [Related]
14. Combination of Tertiary Lymphoid Structure and Neutrophil-to-Lymphocyte Ratio Predicts Survival in Patients With Hepatocellular Carcinoma.
Wen S; Chen Y; Hu C; Du X; Xia J; Wang X; Zhu W; Wang Q; Zhu M; Chen Y; Shen B
Front Immunol; 2021; 12():788640. PubMed ID: 35095864
[TBL] [Abstract] [Full Text] [Related]
15. The circROBO1/KLF5/fus feedback loop regulates the liver metastasis of breast cancer by inhibiting the selective autophagy of afadin.
Wang Z; Yang L; Wu P; Li X; Tang Y; Ou X; Zhang Y; Xiao X; Wang J; Tang H
Mol Cancer; 2022 Jan; 21(1):29. PubMed ID: 35073911
[TBL] [Abstract] [Full Text] [Related]
16. Quantitative washout in patients with hepatocellular carcinoma undergoing TACE: an imaging biomarker for predicting prognosis?
Müller L; Hahn F; Jungmann F; Mähringer-Kunz A; Stoehr F; Halfmann MC; Pinto Dos Santos D; Hinrichs J; Auer TA; Düber C; Kloeckner R
Cancer Imaging; 2022 Jan; 22(1):5. PubMed ID: 35016731
[TBL] [Abstract] [Full Text] [Related]
17. Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinoma.
Ding GY; Ma JQ; Yun JP; Chen X; Ling Y; Zhang S; Shi JY; Chang YQ; Ji Y; Wang XY; Tan WM; Yuan KF; Yan B; Zhang XM; Liang F; Zhou J; Fan J; Zeng Y; Cai MY; Gao Q
J Hepatol; 2022 Mar; 76(3):608-618. PubMed ID: 34793865
[TBL] [Abstract] [Full Text] [Related]
18. Combined inhibition of AURKA and HSF1 suppresses proliferation and promotes apoptosis in hepatocellular carcinoma by activating endoplasmic reticulum stress.
Shen Z; Yin L; Zhou H; Ji X; Jiang C; Zhu X; He X
Cell Oncol (Dordr); 2021 Oct; 44(5):1035-1049. PubMed ID: 34176092
[TBL] [Abstract] [Full Text] [Related]
19. Peritumoral Tertiary Lymphoid Structures Correlate With Protective Immunity and Improved prognosis in Patients With Hepatocellular Carcinoma.
Li H; Liu H; Fu H; Li J; Xu L; Wang G; Wu H
Front Immunol; 2021; 12():648812. PubMed ID: 34122408
[TBL] [Abstract] [Full Text] [Related]
20. [Role of Palliative Care in the Introduction of Chemotherapy in Patients with Poor Performance Status].
Sato I; Nakaya N; Obara Y; Kurosaka N; Ueno S; Nakajima H
Gan To Kagaku Ryoho; 2021 May; 48(5):735-737. PubMed ID: 34006726
[TBL] [Abstract] [Full Text] [Related]
[Next]